Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

5.46

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

-0.12

EPS Last/This Y

-0.09

EPS This/Next Y

-0.1

Price

17.09

Target Price

32.57

Analyst Recom

1.57

Performance Q

-19.98

Relative Volume

0.96

Beta

0.72

Ticker: NVCR



23 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-14NVCR16.560.140.3214903
2025-04-15NVCR16.440.140.0615006
2025-04-16NVCR15.810.140.0515100
2025-04-17NVCR15.570.120.1414938
2025-04-18NVCR15.580.120.1414938
2025-04-21NVCR15.590.110.2714307
2025-04-22NVCR16.520.120.0314332
2025-04-23NVCR17.730.110.0214888
2025-04-24NVCR18.530.100.0717241
2025-04-25NVCR18.50.100186085599380.1116751269035518328
2025-04-28NVCR18.310.0923581279674430.2066115702479319326
2025-04-29NVCR18.280.090.7119409
2025-04-30NVCR18.120.090.0319318
2025-05-01NVCR17.950.090.5419396
2025-05-02NVCR18.150.100.1719453
2025-05-05NVCR17.740.100.0519452
2025-05-06NVCR16.330.100.4319552
2025-05-07NVCR16.650.091.1219641
2025-05-08NVCR17.430.100.0719732
2025-05-09NVCR17.390.101.0219726
2025-05-12NVCR18.590.100.0419754
2025-05-13NVCR18.140.100.2919855
2025-05-14NVCR17.090.100.3720057
DateSymbolLastP/C OIP/C VolTotal OI
23 items Current Page1 of 1



23 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-14NVCR16.55-27.8-131.5-1.97
2025-04-15NVCR16.46-27.7-129.0-1.97
2025-04-16NVCR15.82-27.7-119.1-1.97
2025-04-17NVCR15.58-27.7-125.8-1.97
2025-04-18NVCR15.58-27.7-130.6-1.98
2025-04-21NVCR15.60-28.9-131.0-1.98
2025-04-22NVCR16.51-28.9-144.0-1.98
2025-04-23NVCR17.77-28.9-153.1-1.98
2025-04-24NVCR18.50-28.9-121.0-1.98
2025-04-25NVCR18.50-28.9-103.8-1.98
2025-04-28NVCR18.31-25.8-59.5-1.65
2025-04-29NVCR18.29-25.8-82.1-1.65
2025-04-30NVCR18.14-25.8-80.5-1.65
2025-05-01NVCR17.95-25.8-80.1-1.65
2025-05-02NVCR18.15-25.8-84.9-1.65
2025-05-05NVCR17.76-25.8-77.5-1.65
2025-05-06NVCR16.32-25.8-64.0-1.65
2025-05-07NVCR16.65-25.8-86.8-1.65
2025-05-08NVCR17.42-25.8-92.9-1.65
2025-05-09NVCR17.39-25.8-81.7-1.65
2025-05-12NVCR18.57-25.8-97.9-1.65
2025-05-13NVCR18.14-25.8-77.1-1.65
2025-05-14NVCR17.09-25.8-69.3-1.65
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
23 items Current Page1 of 1



23 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-14NVCR-0.40-1.365.51
2025-04-15NVCR-0.40-1.365.51
2025-04-16NVCR-0.40-1.365.51
2025-04-17NVCR-0.40-1.365.51
2025-04-18NVCR-0.40-1.365.51
2025-04-21NVCR-0.40-1.295.51
2025-04-22NVCR-0.40-1.295.51
2025-04-23NVCR-0.40-1.295.51
2025-04-24NVCR-0.39-1.295.43
2025-04-25NVCR-0.39-1.295.43
2025-04-28NVCR-0.39-1.215.15
2025-04-29NVCR-0.39-1.215.15
2025-04-30NVCR-0.39-1.215.15
2025-05-01NVCR-0.39-1.215.15
2025-05-02NVCR-0.39-1.215.15
2025-05-05NVCR-0.39-5.565.15
2025-05-06NVCR-0.39-5.565.15
2025-05-07NVCR-0.39-5.565.15
2025-05-08NVCR-0.39-5.565.15
2025-05-09NVCR-0.39-5.565.15
2025-05-12NVCR-0.39-2.285.46
2025-05-13NVCR-0.39-2.285.46
2025-05-14NVCR-0.39-2.285.46
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
23 items Current Page1 of 1

Last Quarter Act. EPS​

-0.31

Avg. EPS Est. Current Quarter

-0.39

Avg. EPS Est. Next Quarter

-0.43

Insider Transactions

-0.39

Institutional Transactions

-2.28

Beta

0.72

Average Sales Estimate Current Quarter

153

Average Sales Estimate Next Quarter

156

Fair Value

Quality Score

31

Growth Score

43

Sentiment Score

65

Actual DrawDown %

92.7

Max Drawdown 5-Year %

-95.1

Target Price

32.57

P/E

Forward P/E

PEG

P/S

3.07

P/B

5.27

P/Free Cash Flow

EPS

-1.51

Average EPS Est. Cur. Y​

-1.65

EPS Next Y. (Est.)

-1.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-26.41

Relative Volume

0.96

Return on Equity vs Sector %

-69

Return on Equity vs Industry %

-63.3

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.4

EBIT Estimation

-69.3
NovoCure Limited
Sector: Healthcare
Industry: Medical Devices
Employees: 1488
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
stock quote shares NVCR – NovoCure Limited Stock Price stock today
news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch NVCR – NovoCure Limited yahoo finance google finance
stock history NVCR – NovoCure Limited invest stock market
stock prices NVCR premarket after hours
ticker NVCR fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Facebook-f Twitter Tiktok Instagram Youtube

Get Started

About